NCT01015521View on ClinicalTrials.gov

Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer

PHASE2WithdrawnINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2012

Conditions
Breast Neoplasm
Interventions
DRUG

Aminoflavone Prodrug

Aminoflavone Prodrug administered D1, D8 of 21-day cycle

Sponsors
All Listed Sponsors
lead

Tigris Pharmaceuticals

INDUSTRY

NCT01015521 - Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer | Biotech Hunter | Biotech Hunter